Dermata Therapeutics (DRMA) Other Operating Expenses (2021 - 2025)
Dermata Therapeutics (DRMA) posted quarterly Other Operating Expenses of -$5.7 million for Q1 2025, down 1534.44% year-over-year from $398682.1 in Q1 2024, and down 22648.95% quarter-over-quarter from -$25139.0 in Q4 2024.
Dermata Therapeutics (DRMA) Other Operating Expenses (2021 - 2025) Analysis & Trends
Dermata Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$5.7 million for Q1 2025.
- In Q1 2025, Other Operating Expenses fell 1534.44% year-over-year to -$5.7 million; the TTM figure through Dec 2025 stood at -$5.7 million (down 1307.42% YoY), while the FY2024 annual figure was -$406336.0, down 23.74% from the prior year.
- Other Operating Expenses for Q1 2025 stood at -$5.7 million, down from -$25139.0 in the prior quarter.
- The five-year high for Other Operating Expenses was -$14985.0 in Q2 2024, with the low at -$5.7 million in Q1 2025.
- The 5-year median for Other Operating Expenses is -$120257.0 (2022), against an average of -$584164.8.
- The sharpest annual moves came in 2022 and 2025: Other Operating Expenses jumped 86.63% in 2022, then plunged 1534.44% in 2025.
- Dermata Therapeutics' Other Operating Expenses stood at -$1.2 million in 2021, then surged by 86.63% to -$165983.0 in 2022, then surged by 51.78% to -$80043.0 in 2023, then soared by 68.59% to -$25139.0 in 2024, then sank by 22648.95% to -$5.7 million in 2025.
- Business Quant data shows DRMA's Other Operating Expenses at -$5.7 million in Q1 2025, -$25139.0 in Q4 2024, and -$16315.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5.72 Mn |
| Dec 31, 2024 | -25,139.00 |
| Sep 30, 2024 | -16,315.00 |
| Jun 30, 2024 | -14,985.00 |
| Mar 31, 2024 | -349,897.00 |
| Dec 31, 2023 | -80,043.00 |
| Sep 30, 2023 | -82,752.00 |
| Jun 30, 2023 | -82,752.00 |
| Mar 31, 2023 | -82,835.00 |
| Dec 31, 2022 | -165,983.00 |
| Sep 30, 2022 | -180,076.00 |
| Jun 30, 2022 | -208,263.00 |
| Mar 31, 2022 | -157,679.00 |
| Dec 31, 2021 | -1.24 Mn |
| Sep 30, 2021 | -30,075.00 |
| Mar 31, 2021 | -909,822.00 |